milan klower Interactive Climate Modelling Klöwer JuliaEO26 EGU22 - WeAreEGU, Milan Klöwer
Description
I had my 1st dose on April 9
A phase I dose-escalation study of IMGN388 in patients with solid tumors
1c), and attenuated myeloid-biased differentiation in peripheral blood (Fig
HIF-1alpha protein levels and translational activity is compromised by methylglyoxal through different mechanisms which are elegantly described elsewhere 43
